Clinical Trial Detail

NCT ID NCT01976585
Title In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Joshua Brody
Indications

mycosis fungoides

B-cell lymphoma

CLL/SLL

cutaneous T cell lymphoma

marginal zone B-cell lymphoma

follicular lymphoma

Therapies

CDX-301 + Poly ICLC

Age Groups: adult

No variant requirements are available.